HCPCS code Q4154 – Biovance amniotic membrane allograft billing

Key takeaways

HCPCS code Q4154 describes Biovance, an amniotic membrane allograft, billed per square centimeter of surface area applied.

Medicare reimburses Q4154 at approximately $127 per cm2, and units must equal the exact wound surface area covered.

Many Medicare Advantage and Medicaid managed care plans require prior authorization before application.

Pabau’s claims software holds a claim back until required details, such as the authorization code, are filled in.

HCPCS code Q4154: Definition and code details

HCPCS code Q4154 describes Biovance, an amniotic membrane allograft, per square centimeter. It is a Level II code maintained by the Centers for Medicare and Medicaid Services (CMS). It sits within the Q4100-Q4299 series reserved for skin substitute products under Medicare’s fee-for-service and managed care programs.

Biovance is manufactured by Celularity. It is a dehydrated, decellularized amniotic membrane derived from human placental tissue. Biovance is a human tissue product. Tissue products like it are coded with HCPCS Q-codes, while drugs take J-codes and procedures take CPT codes.

What Q4154 covers and what it excludes

Q4154 covers the supply of Biovance amniotic membrane allograft when applied to an appropriate wound. Coverage is contingent on the wound type, the clinical setting, and the payer’s local coverage determination (LCD).

Covered wound types

• Diabetic foot ulcers (DFU) and lower extremity diabetic wounds
• Venous leg ulcers
• Pressure injuries (stage 3 and 4)
• Chronic wounds that have failed conventional treatment for four or more weeks
• Post-surgical wounds with delayed healing

What Q4154 does not cover

• Acute traumatic wounds not requiring advanced wound care
• Burns covered by other HCPCS codes
• Applications of a different amniotic or skin substitute product (each has its own Q-code)
• The application procedure itself, which is billed separately using CPT codes 15271-15278

A common billing error is using Q4154 when a different amniotic product was applied. The code is product-specific. If a clinician switches from Biovance to EpiFix mid-treatment, the code changes to Q4186 (EpiFix).

How to calculate and bill units for Q4154

Units for Q4154 equal the total surface area of Biovance applied, measured in square centimeters. Measure the wound at its widest length and widest width, then multiply length (cm) by width (cm) to get the units to bill.

Bill only the area actually covered by the product, not the full wound area if the graft did not cover the entire surface. Accurate wound measurement is both a billing requirement and a medical record necessity.

Rates are approximate based on the ~$127/cm2 Medicare reference rate. Always verify the current rate using the CMS Physician Fee Schedule lookup tool, as rates update annually on January 1.

Q4154 is always billed alongside a companion CPT application code from the 15271-15278 series. On the trunk, arms or legs, 15271 covers the first 25 cm2. The CPT code captures the work of applying the graft, and Q4154 captures the product cost. Both must appear on the same claim.

ICD-10 diagnosis codes used with Q4154

The diagnosis code on a Q4154 claim must match the wound type being treated and must satisfy the payer’s LCD criteria for skin substitute coverage. Mismatched or insufficiently specific ICD-10 codes are among the top three denial triggers for this code.

Use the most specific code available in the ICD-10-CM code set. “Unspecified” ulcer codes frequently trigger automated denials under MAC LCDs because they do not confirm the clinical criteria for skin substitute coverage. When a diabetic foot ulcer is the primary diagnosis, code E11.621 first, then the L97 series to specify the anatomical site and depth.

Medicare reimbursement rate for Q4154 billing

Medicare reimburses Q4154 at approximately $127 per square centimeter in 2026. Under the CY2026 Physician Fee Schedule final rule, CMS pays skin substitutes as incident-to supplies at one flat rate. The same rate applies in the physician office and the hospital outpatient department.

Payment is calculated by multiplying the number of units billed by the per-unit rate. For a 24-unit claim (4 cm x 6 cm wound), the Medicare payment would be approximately $3,048. The 2026 rate is a single national rate, with no geographic adjustment.

In Pabau’s practice claims software, every claim sits on one dashboard with its status, from pending to paid. Log each application session as its own encounter when Biovance is applied across several visits, so units stay tied to the right date of service.

Prior authorization requirements for Q4154

Traditional Medicare (Parts A and B) does not require prior authorization for Q4154, but most Medicare Advantage plans and Medicaid managed care plans do. Submitting a Q4154 claim without a required PA is the single most common reason for denial on this code.

Check insurance eligibility verification before each application session, not just at the start of a treatment course. PA approvals can lapse mid-treatment if the wound has not responded as expected. Some payers also require re-authorization after a set number of applications.

PA documentation typically requires:

• Confirmed diagnosis with wound type and chronicity
• Wound measurement records
• Photos taken at least four weeks apart
• Documentation of failed conventional wound care
• The product lot number or purchase order

Requirements vary by plan year, so verify directly with the payer before each application course.

Q4154 vs similar skin substitute codes: Avoiding mix-ups

Q4154 is one of over 100 HCPCS Q-codes for skin substitute products. Each code is product-specific. Billing the wrong code is incorrect coding, even for a clinically equivalent product. It can trigger a refund demand or a compliance audit.

Never substitute Q4100 (the “not otherwise specified” catch-all) for Q4154. Payers who cover Biovance by name will deny a Q4100 claim for the same product on the grounds that a specific code exists. The reverse is also true: Q4100 is the correct code only when no product-specific code has been assigned by CMS.

Product codes also change over time. EpiFix used to share Q4131 with Epicord until 2019, when CMS split them into Q4186 and Q4187.

Use the AAPC HCPCS code lookup or the PGM Billing HCPCS tool to confirm the current code assignment. Do it before each product’s first claim in a plan year.

Q4154 documentation requirements

Strong documentation is the foundation of every successful Q4154 claim. Medicare Administrative Contractors (MACs) and managed care plans frequently audit skin substitute claims because of their high per-unit cost. Missing a single required element is enough to trigger a full recoupment demand.

The medical record must contain all of the following before a claim is submitted. Good medical billing compliance practice means building this checklist into the clinical workflow, not the billing workflow.

• Wound measurement log: Recorded at each encounter, with length x width (and depth where relevant), in centimeters
• Wound photographs: Date-stamped, showing wound dimensions and healing progress across visits
• Diagnosis confirmation: ICD-10 code supported by the clinical note (for example, a confirmed diabetic foot ulcer with wound depth and chronicity documented)
• Treatment failure history: Documentation of four or more weeks of conventional wound care (moist dressings, offloading, compression) before skin substitute application
• Product lot or batch number: Required for traceability. Include it on the claim or in the supporting record
• Quantity applied: Total surface area covered, matching the units billed on the claim
• Prescribing or ordering clinician: Must be enrolled in Medicare and have ordering authority

Common denial reasons for Q4154 claims

Q4154 claims have a higher-than-average denial rate compared with standard wound care codes. Diagnosis, units, documentation and PA all have to line up on the same claim. The table below shows the most common denial triggers and the prevention step for each.

A structured approach to denial management in healthcare means tracking Q4154 denials by reason code, not just by volume. A practice that sees repeated CO-197 denials (prior authorization missing) has a workflow problem at the point of scheduling. One that sees repeated CO-4 denials (modifier issue) has a coding problem at claim creation. The five checks below run in visit order, and each one blocks a denial trigger from the table.

Medicaid and commercial payer coverage for Q4154

Medicaid coverage for Q4154 is highly variable. Some state fee-for-service Medicaid programs cover amniotic membrane allografts under their skin substitute policy. Others exclude them entirely or limit coverage to a narrow list of approved products. Always verify with the state Medicaid agency or the managed care plan before treatment.

Commercial payers follow their own medical policies. Most large carriers (Aetna, Cigna, UnitedHealthcare commercial) have specific skin substitute policies that list covered products, required diagnoses, and maximum application frequency. Biovance’s coverage status under commercial plans varies by market and plan year.

How claims software reduces Q4154 denials

Most Q4154 denials start before anyone builds the claim. A PA nobody checked, or a wound size that never made it into the note, is enough to stop payment.

Pabau keeps each patient’s insurer and policy on their record, so every invoice routes to the right payer automatically. In the US, it connects to Claim.MD for electronic submission, real-time eligibility checks and claim status tracking.

Before a claim sends, Pabau checks that required details such as authorization codes are filled in. If one is missing, the Send button stays disabled until someone adds it. A Biovance claim to a Medicare Advantage or managed Medicaid plan can’t go out without its PA number.

Reduce billing errors on high-cost wound care claims

Pabau checks each claim for required details like authorization codes before it sends, then tracks it through to payment. See how it fits your wound care billing.

Book a demo

Conclusion

Q4154 pays well per unit, which is exactly why payers audit it so closely. Practices that bill Biovance without denials measure, photograph and confirm PA at the bedside, during each application visit.

Start with the next Biovance patient on your schedule. Check their plan’s PA rule, record the wound in centimeters, and bill only the area the graft covered. A few extra minutes per visit cost far less than a recoupment demand months later.

A clean claim on the first pass is the cheapest Q4154 claim you will ever file. Book a demo to see how Pabau catches a missing authorization code before your wound care claim goes out.

Continue your research

Want to reduce claim denials across your practice? Denial management in healthcare covers the root causes behind denied claims and how to build a prevention-first billing workflow.

Billing the graft application too? CPT code 15271 explains the skin substitute application code that sits on the same claim as Q4154.

Switching a patient from Biovance to Epicord? HCPCS code Q4187 covers Epicord units and 2026 payment.

Need a primer on how clearinghouses process wound care claims? Medical claims clearinghouse explains how electronic claims are validated and routed to payers.

New to the revenue cycle? What is medical billing breaks down the end-to-end revenue cycle process for wound care and specialty practices.

Frequently asked questions